Domov › Crohnova choroba › South Carolina
Klinické štúdie Crohnova choroba v štáte South Carolina
12 štúdií pre Crohnova choroba hľadá účastníkov v zariadeniach v štáte South Carolina.
Mestá v štáte South Carolina
Oficiálny text štúdie (anglicky)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Associates - Patewood /ID# 283870, Greenville
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville
Prebieha náborFáza 4
Vek 18 až 80 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gastroenterology Associates of Orangeburg /ID# 267548, Orangeburg
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06548542A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Gastroenterology Associates, PA, Greenville
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06233461A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Palmetto Primary and Specialty Care Physicians, Charleston, Summerville
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07499232Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Associates - Patewood, Greenville
Prebieha náborFáza 3
Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Johns Hopkins University Gastroenterology and Hepatology-Site Number: 8400116, Columbia
- Biocentric Health Research Center-Site Number: 8400089, Columbia
Prebieha náborFáza 3
Vek 16 až 80 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Palmetto Gastroenterology Clinical Research, Summerville
Prebieha náborFáza 2
Vek 18 až 85 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06226883A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Medical University of South Carolina, North Charleston
Prebieha náborFáza 3
Vek 2 až 17 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06100289A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Medical University of South Carolina, Charleston
Prebieha náborFáza 3
Vek 2 až 17 · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT06405087A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Greenville
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 12. 3. 2026 · NCT07113522VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Medical University of South Carolina (MUSC), Charleston
Prebieha náborFáza 4
Vek 18 až 80 · Všetky pohlavia · Aktualizované 15. 1. 2026 · NCT06257706Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.